Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0002132062-26-000004

Options or other derivatives

  • Chief Medical Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Angelov Angel S Chief Medical Officer 2026-05-18 Grant or award · Stock Option (Right to Buy) +150,000 150,000 D: show line 1 in the form
Loading xslF345X06/form4-05192026_080513.xml…